Routine Cardiac Troponin Measurement in Elderly Surgery Patients
The study aims to observe how routine cardiac troponin measurements affect surgical mortality rates within 30 days in elderly patients undergoing surgery.
Data Collection
Collected from today forward - ProspectiveCohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: August 23, 2018
Actual date on which the first participant was enrolled.This study is focused on understanding how measuring a specific protein in the blood, known as cardiac troponin (hsTnT), can affect the outcomes for elderly patients undergoing major surgery. Cardiac troponin levels often rise due to heart muscle damage, but they can also elevate due to other issues like kidney problems or infections. High levels of this protein are commonly found in hospitalized patients and have been linked to a higher risk of death, even for those not having a heart attack. The study aims to find out if routinely checking troponin levels, along with assessing heart function, can help improve the health outcomes of elderly patients after surgery. Participants in the study will have their troponin levels measured before and after surgery. Additionally, a heart function test called transthoracic echocardiography will assess the heart's ability to relax and fill with blood, both before and after the surgical procedure. The main focus is on seeing if these measurements can predict or reduce the risk of death within 30 days after surgery. This information could be crucial in better understanding and potentially improving the care and recovery of elderly surgical patients.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.63 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 75 to 100 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: * All patients ≥75 y undergoing elective and major surgery till we have collected an entire dataset of 100 patients. * Only those patients will be included who are planned for elective and major surgery. Exclusion Criteria: * Patients under the age of 75 * Intraoperative mortality * Eye surgery * Cardiac or thoracic surgery * Patients undergoing surgery which is not withheld as major surgery * For patients undergoing multiple surgeries for the same indication and during the same hospitalization, only the first surgery will be included
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location